180 Life Sciences Corp.180 Life Sciences Corp.180 Life Sciences Corp.

180 Life Sciences Corp.

No trades
See on Supercharts
Market capitalization
‪1.55 M‬USD
−64.3359USD
‪−19.94 M‬USD
‪517.55 K‬
Beta (1Y)
−1.67

About 180 Life Sciences Corp.

CEO
Jim N. Woody
Headquarters
Palo Alto
Employees (FY)
4
Founded
2016
FIGI
BBG00H1CP5Z7
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.